Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Uterine Corpus Leiomyosarcoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Sarcoma (668
)
Soft Tissue Sarcoma (443
)
Spindle Cell Sarcoma (100
)
Leiomyosarcoma (54
)
Osteosarcoma (54
)
Ewing Sarcoma (45
)
Fibrosarcoma (34
)
Rhabdomyosarcoma (34
)
Liposarcoma (25
)
Kaposi Sarcoma (13
)
Neurofibrosarcoma (13
)
Sarcoma (668
)
Soft Tissue Sarcoma (443
)
Spindle Cell Sarcoma (100
)
Leiomyosarcoma (54
)
Osteosarcoma (54
)
Ewing Sarcoma (45
)
Fibrosarcoma (34
)
Rhabdomyosarcoma (34
)
Liposarcoma (25
)
Kaposi Sarcoma (13
)
Neurofibrosarcoma (13
)
›
Associations
(23)
News
Trials
Search handles
@Dr_R_Kurzrock
@JTrentMDPhD
Search handles
@Dr_R_Kurzrock
@JTrentMDPhD
Filter by
Latest
1year
This presentation by Dr. Michal on PLAG1-rearranged uterine leiomyosarcomas show heterogenous morphology which show lipomatous/osteochondromatous differentiation are observed to behave aggressively Further establishing how #molpath continues to enhance #gynpath! #uscap2023 (@anueru432)
1 year ago
SKAP2 (Src Kinase Associated Phosphoprotein 2) • PLAG1 (PLAG1 Zinc Finger)
over1year
Study led by @MDAndersonNews Dr. Timothy Yap. It’s a nuanced conclusion, and there is no tumor agnostic indication that will emerge here. Beyond “BRCA” cancers (#BreastCancer, #OvarianCancer, #PancreaticCancer & #ProstateCancer) the one surprise is uterine leiomyosarcoma. (@Aiims1742)
over 1 year ago
Pan tumor
|
BRCA (Breast cancer early onset)
almost2years
Congrats Dr. Sam Bose on identifying lack of Rad51 and WES alterations associated with favorable outcome EFS in patients with uterine #leiomyosarcoma #ASCO22 #Sarcoma (@JTrentMDPhD)
almost 2 years ago
Clinical
|
RAD51 (RAD51 Homolog A)
2years
ALK as another tumor agnostic marker? MyPath pilot for alectinib. Disease control rate = 60% in ALK rearranged including PRs in colon and pancreatic and uterine leiomyosarcoma. No responses in ALK mutated or amplified (@Dr_R_Kurzrock)
2 years ago
Pan tumor
|
ALK (Anaplastic lymphoma kinase)
|
ALK rearrangement • ALK mutation
|
Alecensa (alectinib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login